CA2383570A1 - Pourable liquid vehicles - Google Patents

Pourable liquid vehicles Download PDF

Info

Publication number
CA2383570A1
CA2383570A1 CA002383570A CA2383570A CA2383570A1 CA 2383570 A1 CA2383570 A1 CA 2383570A1 CA 002383570 A CA002383570 A CA 002383570A CA 2383570 A CA2383570 A CA 2383570A CA 2383570 A1 CA2383570 A1 CA 2383570A1
Authority
CA
Canada
Prior art keywords
liquid vehicles
pourable liquid
compositions
substances
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002383570A
Other languages
French (fr)
Other versions
CA2383570C (en
Inventor
Douglas Joseph Dobrozsi
Jerry William Ii Hayes
Bjorn Olof Lindman
Rouja Hristova Ivanova
Paschalis Alexandridis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
The Procter & Gamble Company
Douglas Joseph Dobrozsi
Jerry William Ii Hayes
Bjorn Olof Lindman
Rouja Hristova Ivanova
Paschalis Alexandridis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company, Douglas Joseph Dobrozsi, Jerry William Ii Hayes, Bjorn Olof Lindman, Rouja Hristova Ivanova, Paschalis Alexandridis filed Critical The Procter & Gamble Company
Publication of CA2383570A1 publication Critical patent/CA2383570A1/en
Application granted granted Critical
Publication of CA2383570C publication Critical patent/CA2383570C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

The present invention covers pourable liquid vehicles that can be combined with compositions, materials and substances.
Among the benefits of such pourable liquid vehicles the compositions are retained on the moistened surface for a period of time sufficient to allow compositions, materials and substances to act on said surface, resisting erosion or run-off from additional moisture being applied. Such pourable liquid vehicles have a number of utilities including but not limited to cleaning and treating surfaces of objects as well as biological or living organisms, including living creatures.
CA002383570A 1999-09-11 2000-09-11 Pourable liquid vehicles Expired - Fee Related CA2383570C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15326099P 1999-09-11 1999-09-11
US60/153,260 1999-09-11
PCT/US2000/024732 WO2001019329A2 (en) 1999-09-11 2000-09-11 Polyoxyalkylene copolymers containing pourable liquid vehicles

Publications (2)

Publication Number Publication Date
CA2383570A1 true CA2383570A1 (en) 2001-03-22
CA2383570C CA2383570C (en) 2008-08-12

Family

ID=22546438

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002383570A Expired - Fee Related CA2383570C (en) 1999-09-11 2000-09-11 Pourable liquid vehicles

Country Status (12)

Country Link
US (1) US6503955B1 (en)
EP (1) EP1212091B1 (en)
JP (1) JP2003509350A (en)
CN (1) CN1373674A (en)
AT (1) ATE355082T1 (en)
AU (1) AU770516B2 (en)
CA (1) CA2383570C (en)
DE (1) DE60033671T2 (en)
ES (1) ES2282134T3 (en)
MX (1) MXPA02002607A (en)
TR (1) TR200200616T2 (en)
WO (1) WO2001019329A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ517706A (en) 1999-10-08 2004-01-30 Affinium Pharm Inc Fab I inhibitors
PT1321140E (en) * 2000-08-25 2005-06-30 Kowa Co IBUPRHENE SOLUTIONS FOR FILLING CAPSULES AND CAPSULA PREPARATIONS
MXPA03004546A (en) * 2000-11-22 2003-09-10 Rxkinetix Inc Treatment of mucositis.
ES2320984T3 (en) 2001-04-06 2009-06-01 Affinium Pharmaceuticals, Inc. FAB INHIBITORS I.
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
FR2838349B1 (en) * 2002-04-15 2004-06-25 Laurence Paris LIQUID COMPOSITIONS FOR SUSTAINED RELEASE SOFT CAPSULES AND PROCESS FOR PRODUCING THE SAME
CA2508792C (en) * 2002-12-06 2013-02-05 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
US20060140985A1 (en) * 2003-01-10 2006-06-29 Zhong Zhang Lansoprazole formulations and related processes and methods
JP4880448B2 (en) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ，インコーポレーテッド Composition comprising a plurality of antibiotics and method of using the same
JP2006008696A (en) * 2003-03-20 2006-01-12 Mitsubishi Pharma Corp Pharmaceutical preparation containing arginine amides
EP1617277B1 (en) * 2003-04-03 2009-05-27 Seed Co., Ltd. Ophthalmic lenses capable of sustained drug release and preservative solutions therefor
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
CA2545947A1 (en) * 2003-12-11 2005-07-07 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
ES2515101T3 (en) * 2004-06-04 2014-10-29 Debiopharm International Sa Acrylamide derivatives as antibiotic agents
CN1311873C (en) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 Temperature sensitive gel formulation for in situ vagina uses
US20060115785A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics
CA2635603C (en) * 2005-11-30 2016-01-19 Endo Pharmaceuticals Inc. Treatment of xerostomia
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
US20070196329A1 (en) * 2006-01-20 2007-08-23 Erning Xia Disinfection efficacy of lens care regimen for rigid gas permeable contact lenses
EA026670B1 (en) * 2006-03-10 2017-05-31 Лабосвисс Аг Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
EP2125802A4 (en) * 2007-02-16 2014-08-20 Debiopharm Int Sa Salts, prodrugs and polymorphs of fab i inhibitors
EP2694113A4 (en) * 2011-04-01 2014-11-12 Univ Florida Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
ITFI20110241A1 (en) * 2011-11-03 2013-05-04 Lo Li Pharma Srl FORMULATIONS TO IMPROVE THE PROBABILITY OF FECONDATION AND THE NUMBER OF PREGNANCIES
SI2861608T1 (en) 2012-06-19 2019-08-30 Debiopharm International Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
UY36570A (en) * 2015-02-26 2016-10-31 Merial Inc INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES OF THE SAME
CA3014541A1 (en) 2016-02-26 2017-08-31 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
US11400047B2 (en) 2017-02-01 2022-08-02 Johnson & Johnson Consumer Inc. Lozenge comprising micronized benzocaine and polyethylene glycol

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100271A (en) 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4511563A (en) 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness
IL79552A0 (en) 1985-07-30 1986-10-31 Int Minerals & Chem Corp Stabilization of growth promoting hormones
DE3532562A1 (en) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg TRANSDERMALLY RESORBABLE, WATER-BASED PREPARATIONS OF ARYLPROPIONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
US5030448A (en) 1986-05-15 1991-07-09 Emory University Method of delivering drugs to damaged or diseased tissue
US4810503A (en) 1987-03-31 1989-03-07 Basf Corporation Polymers which form gels at low concentrations in water
US4911926A (en) 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions
US5681576A (en) * 1988-11-16 1997-10-28 Mdv Technologies, Inc. Method and composition for post surgical adhesion reduction
US5135751A (en) 1988-11-16 1992-08-04 Mediventures Incorporated Composition for reducing postsurgical adhesions
US5256396A (en) 1990-01-24 1993-10-26 Colgate-Palmolive Company Topical composition
US5300295A (en) 1990-05-01 1994-04-05 Mediventures, Inc. Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
US5298260A (en) 1990-05-01 1994-03-29 Mediventures, Inc. Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality
US5292516A (en) 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
US5306501A (en) 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5143731A (en) 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5071644A (en) 1990-08-07 1991-12-10 Mediventures, Inc. Topical drug delivery with thermo-irreversible gels
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
CN1106259A (en) 1994-02-05 1995-08-09 日东制药株式会社 Antiphlogistic and analgesic gel agent for external use containing propanoic acid non steroid pharmaceutical as effective composition
AU1332997A (en) 1995-12-11 1997-07-03 Mdv Technologies, Inc. Ophthalmic composition comprising polyoxyethylene-polyoxypropylene polymers

Also Published As

Publication number Publication date
EP1212091A2 (en) 2002-06-12
CN1373674A (en) 2002-10-09
AU770516B2 (en) 2004-02-26
US6503955B1 (en) 2003-01-07
ES2282134T3 (en) 2007-10-16
MXPA02002607A (en) 2002-07-30
CA2383570C (en) 2008-08-12
TR200200616T2 (en) 2002-06-21
WO2001019329A2 (en) 2001-03-22
DE60033671D1 (en) 2007-04-12
WO2001019329A3 (en) 2001-08-02
AU7128200A (en) 2001-04-17
JP2003509350A (en) 2003-03-11
ATE355082T1 (en) 2006-03-15
DE60033671T2 (en) 2007-12-06
EP1212091B1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
CA2383570A1 (en) Pourable liquid vehicles
GR3024043T3 (en) Antifouling coating composition.
AU3717100A (en) Herbicidal compositions containing plant essential oils and mixtures or blends thereof
CA2167971A1 (en) Solid acid cleaning block and method of manufacture
ID22477A (en) PREVENTION OF COLOR CHANGE IN THE COMPOSITION OF THE COATING CONTAINING PIRITIONA
AU5378199A (en) Hard surface cleaning and disinfecting compositions
EP0638636A3 (en) Hard surface detergent compositions.
DE69728594D1 (en) Chromium-free composition for the treatment of metal surfaces
ZA9710122B (en) Improvements in or relating to organic compositions.
ATE433280T1 (en) BIOSTATIC COATINGS TO REDUCE AND PREVENT BACTERIAL ATTACHMENTS
CA2204626A1 (en) Hydrocarbyl containing coatings, compositions and methods of use
BR9306962A (en) Hard surface cleaning composition
CA2454516A1 (en) Method of cleaning floors
AU1973900A (en) Fuel additive and fuel composition containing the same
ZA979897B (en) Improvements in or relating to organic compositions.
ID26395A (en) GAMMA-AMINOBUTIRAT ACID DEPOSIT CONTAINING SOLID COMPOSITION AND THE PROCESS OF MAKING
AU5372096A (en) Detergent compositions containing fragrance precursors and the fragrance precursors themselves
AU3519300A (en) Nematicidal compositions containing plant essential oils and mixtures or blends thereof
AU3802295A (en) Sea water-erodible antifouling paint composition
AU1915399A (en) Cs-1 peptidomimetics, compositions and methods of using the same
AU3999599A (en) Polyolefin compositions having variable toughness and/or hardness
CA2422678A1 (en) Compositions and methods for treating surfaces
EP0659848A3 (en) Coating composition and antifouling paint.
GB2304115B (en) Pine oil hard surface cleaning compositions
AU4488297A (en) Detergent composition or component

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160912